<VariationArchive VariationID="2683853" VariationName="NC_000001.11:g.(155747068_155747546)_(155611487_155611965)del" VariationType="Deletion" Accession="VCV002683853" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2024-07-15" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2844890" VariationID="2683853">
      <GeneList>
        <Gene Symbol="DAP3" FullName="death associated protein 3" GeneID="7818" HGNC_ID="HGNC:2673" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>1q22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="155687948" stop="155739010" display_start="155687948" display_stop="155739010" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="155658881" stop="155708800" display_start="155658881" display_stop="155708800" Strand="+" />
          </Location>
          <OMIM>602074</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000001.11:g.(155747068_155747546)_(155611487_155611965)del</Name>
      <VariantType>Deletion</VariantType>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.(155747068_155747546)_(155611487_155611965)del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.(155747068_155747546)_(155611487_155611965)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000001.11:g.(155747068_155747546)_(155611487_155611965)del AND Perrault syndrome 1" Accession="RCV004585047" Version="1">
        <ClassifiedConditionList TraitSetID="6454">
          <ClassifiedCondition DB="MedGen" ID="C4551721">Perrault syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2024-01-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-07-15" MostRecentSubmission="2024-07-15">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="6454" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15884" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS</ElementValue>
                <XRef Type="MIM" ID="233400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Perrault syndrome 1</ElementValue>
                <XRef ID="MONDO:0009300" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ovarian dysgenesis with sensorineural deafness</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PRLTS1</ElementValue>
                <XRef Type="MIM" ID="233400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Perrault syndrome is characterized by sensorineural hearing loss (SNHL) in males and females and ovarian dysfunction in females. SNHL is bilateral and ranges from profound with prelingual (congenital) onset to moderate with early-childhood onset. When onset is in early childhood, hearing loss can be progressive. Ovarian dysfunction ranges from gonadal dysgenesis (absent or streak gonads) manifesting as primary amenorrhea to primary ovarian insufficiency (POI) defined as cessation of menses before age 40 years. Fertility in affected males is reported as normal (although the number of reported males is limited). Neurologic features described in some individuals with Perrault syndrome include learning difficulties and developmental delay, cerebellar ataxia, and motor and sensory peripheral neuropathy.</Attribute>
                <XRef ID="NBK242617" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25254289</ID>
                <ID Source="BookShelf">NBK242617</ID>
              </Citation>
              <XRef ID="2855" DB="Orphanet" />
              <XRef ID="642945" DB="Orphanet" />
              <XRef ID="C4551721" DB="MedGen" />
              <XRef ID="MONDO:0009300" DB="MONDO" />
              <XRef Type="MIM" ID="233400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7901995" SubmissionDate="2024-01-06" DateLastUpdated="2024-07-15" DateCreated="2024-07-15">
        <ClinVarSubmissionID localKey="Chr1(GRCh38):g.(155747068_155747546)_(155611487-155611965)del" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004228993" DateUpdated="2024-07-15" DateCreated="2024-07-15" Type="SCV" Version="1" SubmitterName="Newman Lab, University of Manchester" OrgID="508888" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-06">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="2" />
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">PCR</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DAP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.11:g.(155747068_155747546)_(155611487_155611965)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="233400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14138315</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7901995" TraitType="Disease" MappingType="XRef" MappingValue="233400" MappingRef="OMIM">
        <MedGen CUI="C4551721" Name="Perrault syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

